Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Smith

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Familial Cancer|February 7, 2025
New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patientsJulie Amiot, Lara Gubeljak, Agathe Fontaine, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapyXavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Clinics and Research in Hepatology and Gastroenterology|May 4, 2020
Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departmentsAnne-Sophie Foucan, Pascale Grosclaude, Véronique Bousser, et al.
Fundamental & Clinical Pharmacology|July 29, 2011
Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort studyDenis Smith, Eric Terrebonne, Magali Rouyer, et al.
Clinical Colorectal Cancer|April 18, 2020
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World StudyEric François, Laurent Mineur, Gaël Deplanque, et al.
Journal of Geriatric Oncology|April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohortMagali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
Current Treatment Options in Oncology|September 13, 2023
The Crying Need for a Better Response Assessment in Rectal CancerSamuel Amintas, Nicolas Giraud, Benjamin Fernandez, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR studyMohamed Hebbar, Benoist Chibaudel, Thierry André, et al.
Cancer Research and Treatment|October 11, 2023
NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) Followed by Chemoradiation Based 5FU and Oxaliplatin and SurgeryLaurent Mineur, Frederi Plat, Françoise Desseigne, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Familial Cancer|February 7, 2025
New RPS20 gene variant in colorectal cancer diagnosis: insight from a large series of patientsJulie Amiot, Lara Gubeljak, Agathe Fontaine, et al.
Gastroenterologie Clinique Et Biologique|March 28, 2006
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapyXavier Adhoute, Denis Smith, Véronique Vendrely, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Clinics and Research in Hepatology and Gastroenterology|May 4, 2020
Management of colon cancer patients: A comprehensive analysis of the absence of multidisciplinary team meetings in two French departmentsAnne-Sophie Foucan, Pascale Grosclaude, Véronique Bousser, et al.
Fundamental & Clinical Pharmacology|July 29, 2011
Chemotherapy and targeted agents for colorectal cancer in a real-life setting anticipate guidelines: the COLCHIC cohort studyDenis Smith, Eric Terrebonne, Magali Rouyer, et al.
Clinical Colorectal Cancer|April 18, 2020
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (≥75 Years) Patients With Metastatic Colorectal Cancer: A Real-World StudyEric François, Laurent Mineur, Gaël Deplanque, et al.
Journal of Geriatric Oncology|April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohortMagali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
Current Treatment Options in Oncology|September 13, 2023
The Crying Need for a Better Response Assessment in Rectal CancerSamuel Amintas, Nicolas Giraud, Benjamin Fernandez, et al.
Journal of Chemotherapy (Florence, Italy)|May 21, 2013
Randomized trial of simplified LV5FU2 versus FOLFOX7 followed by FOLFIRI (MIROX) in patients with initially resectable metastatic colorectal cancer: a GERCOR studyMohamed Hebbar, Benoist Chibaudel, Thierry André, et al.
Cancer Research and Treatment|October 11, 2023
NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) Followed by Chemoradiation Based 5FU and Oxaliplatin and SurgeryLaurent Mineur, Frederi Plat, Françoise Desseigne, et al.
Pageof 10